Online inquiry

IVTScrip™ mRNA-Human AK125727, (Cap 0, N1-Methylpseudo-UTP, 120 nt-poly(A))   (CAT#: GTTS-WK14746MR)

This product GTTS-WK14746MR is a type of mRNA having 120 nt poly(A) tail and modified with Cap 0 & N1-Methylpseudo-UTP. It ecodes the AK125727 protein. This product can be used in AXL+SIGLEC6+ dendritic cell-related researches.
Specifications
Product type mRNA
Modified bases N1-Methylpseudo-UTP
5' Cap Cap 0
Species Human
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 100506603
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human AK125727, (Cap 0, N1-Methylpseudo-UTP, 120 nt-poly(A)) (GTTS-WK14746MR). Click the button above to contact us or submit your feedback about this product.

See other products
CAT Product Name Product Type CDs
GTTS-WK20950MR IVTScrip™ mRNA-Human ANP32A-IT1, (Cap 1, 2-Thio-UTP, 30 nt-poly(A)) mRNA ANP32A-IT1
GTTS-WK15945MR IVTScrip™ mRNA-Human AK124399, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA AK124399
GTTS-WK15343MR IVTScrip™ mRNA-Human AK095700, (Cap 0, 2-Thio-UTP, 120 nt-poly(A)) mRNA AK095700
GTTS-WK17143MR IVTScrip™ mRNA-Human AK095700, (Cap 0, 2-Thio-UTP, 30 nt-poly(A)) mRNA AK095700
GTTS-WK20145MR IVTScrip™ mRNA-Human AK124399, (Cap 1, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA AK124399
GTTS-WK17950MR IVTScrip™ mRNA-Human ANP32A-IT1, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA ANP32A-IT1
GTTS-WK28476MR IVTScrip™ mRNA-Human ATP11A-AS1, (Cap 1, 5-Methyl-CTP, 30 nt-poly(A)) mRNA ATP11A-AS1
GTTS-WK21876MR IVTScrip™ mRNA-Human ATP11A-AS1, (Cap 0, Pseudo-UTP, 120 nt-poly(A)) mRNA ATP11A-AS1
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
×

Webinar Register

Simone Pinto Carneiro, Ph.D.

Group Leader, Ludwig-Maximilians-University of Munich

date-time 10AM EDT | May 19, 2026

Register Now →